Assisted reproduction and choice in the biotech age: recommendations for a way forward
By Francine Coeytaux, Marcy Darnovsky, Susan Berke Fogel,
Contraception
| 01. 01. 2011
[Editorial]
To view the PDF version of this article, please scroll down to the bottom of this page.
Over the past several decades, millions of people have used new reproductive technologies in their quest for biologically related children. Access to these technologies has enabled people who suffer from infertility, same-sex couples and single women to form biological families. At the same time, these tools can be used to select the sex of a future child [1] or to “de-select” based on a growing number of genetic markers for disabilities and other conditions [2]. While assisted reproductive technologies have increased parental options for those who can afford them, they pose numerous ethical challenges that the reproductive rights, health and justice communities are only beginning to address.
The assisted reproduction field has so far developed largely outside the realm of public policy and with little public discussion about how new technologies should be used and who should have access to them. Difficult questions have had minimal public airing. Should access to reproductive technologies be limited to those who can pay for them? Should...
Related Articles
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
By Jason Kehe, Wired | 04.11.2024
God help the babies! Or, absent God, a fertility startup called Orchid. It offers prospective parents a fantastical choice: Have a regular baby or have an Orchid baby. A regular baby might grow up and get cancer. Or be born...
By Neel Shah, The Preprint | 04.11.2024
Years ago, I interviewed for a residency position at The Johns Hopkins Hospital in Baltimore. Standing before the domed Victorian building at the campus entrance, I couldn’t help but be in awe of the history of the place, the great...
By Eleanor Hayward and Joanna Crawford, The Times | 03.29.2024
Gazing out at the Mediterranean from an idyllic rocky mountaintop, Sophie Hermann announced to her half a million Instagram followers that she had decided to freeze her eggs. Since that post in August, the 37-year-old former Made in Chelsea star...